Article info
PDFClinical and epidemiological research
Concise report
Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system
- Correspondence to Dr Peter M Izmirly, NYU School of Medicine, Hospital for Joint Diseases, 301 East 17th Street, Room 1611B, New York, NY 10003, USA; Peter.Izmirly{at}nyumc.org
Citation
Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system
Publication history
- Received July 26, 2015
- Revised October 22, 2015
- Accepted November 7, 2015
- First published December 1, 2015.
Online issue publication
October 31, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/